亚太基因组癌症面板和分析市场：按应用、最终用户、国家：分析和预测（2023-2033）

亚太地区基因组癌症检测和分析市场规模预计将从 2023 年的 15.6 亿美元增至 2033 年的 47.8 亿美元。

这一增长是由基因组研究的进步以及对癌症领域精准医疗的日益关注所推动的。

在全部区域癌症发病率上升和个人化医疗日益普及的推动下，亚太地区基因组癌症检测和分析市场正在显着增长。基因组技术的进步和次世代定序（NGS）能力的扩展正在提高癌症诊断和治疗策略的精确度，使治疗能够根据个体的基因谱进行客製化。政府和医疗机构正在增加对医疗基础设施和基因组研究的投资，进一步推动市场扩张。此外，生物技术公司之间的合作正在促进先进基因组测试的普及。大众对早期癌症检测和标靶治疗益处的认识不断提高也支持了这一市场的成长，使亚太地区成为癌症基因组医学领域的重要地区。

该报告研究了亚太地区基因组癌症组合和分析市场，并提供了市场概述，包括按应用、最终用户、国家和进入市场的公司概况分類的趋势。

目录

执行摘要

第一章 市场

• 产品定义
• 纳入与排除标准
• 市场范围
• 调查方法
• 市场概况

第二章 按地区划分

• 概述
• 亚太地区

第三章 公司简介

• Burning Rock DX
• Genecast Biotechnology Co., Ltd

Introduction to Asia-Pacific Genomic Cancer Panel and Profiling Market

The Asia-Pacific genomic cancer panel and profiling market is expected to reach $4.78 billion by 2033 from $1.56 billion in 2023. This growth is driven by advancements in genomic research and an increasing focus on precision medicine within the field of oncology.

Market Introduction

The Asia-Pacific (APAC) Genomic Cancer Panel and Profiling Market is experiencing significant growth, propelled by the rising incidence of cancer and the increasing adoption of personalized medicine across the region. Advances in genomic technologies and the expanding capabilities of next-generation sequencing (NGS) have enhanced the precision of cancer diagnostics and treatment strategies, catering specifically to individual genetic profiles. Governments and healthcare institutions are increasingly investing in healthcare infrastructure and genomic research, further stimulating market expansion. Moreover, collaborations between biotech firms are boosting access to advanced genomic tests. This market's growth is also supported by growing public awareness about the benefits of early cancer detection and targeted therapies, making the APAC region a vital player in the landscape of cancer genomics.

Market Segmentation

Segmentation 1: by Application

• Clinical
• Research

Segmentation 2: by End User

• Hospitals
• Clinical and Diagnostic Laboratories
• Research and Academic Institutes
• Other End Users

Segmentation 3: by Country

• China
• Japan
• India
• Australia
• South Korea
• Rest-of-Asia-Pacific

How can this report add value to an organization?

Product/Innovation Strategy: The Asia-Pacific genomic cancer panel and profiling market has been extensively segmented based on various categories, such as application, end user, and country. This can help readers get a clear overview of the segments accounting for the largest share and the ones that are well-positioned to grow in the coming years.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and regional presence.

Some of the prominent names in this market are:

• Burning Rock DX
• Genecast Biotechnology Co., Ltd

Table of Contents

Executive Summary

1 Markets

• 1.1 Product Definition
• 1.2 Inclusion and Exclusion Criteria
  • 1.2.1 Inclusion Criteria
  • 1.2.2 Exclusion Criteria
• 1.3 Market Scope
  • 1.3.1 Scope of the Study
  • 1.3.2 Key Questions Answered in this Report
• 1.4 Research Methodology
  • 1.4.1 Genomic Cancer Panel and Profiling Market: Research Methodology
  • 1.4.2 Data Sources
  • 1.4.3 Market Estimation Model
  • 1.4.4 Criteria for Company Profiling
• 1.5 Market Overview
  • 1.5.1 Market Definition
  • 1.5.2 Market Footprint and Growth Potential
  • 1.5.3 Future Potential

2 By Region

• 2.1 Overview
• 2.2 Asia-Pacific
  • 2.2.1 Key Dynamics
  • 2.2.2 China
  • 2.2.3 Japan
  • 2.2.4 India
  • 2.2.5 Australia
  • 2.2.6 South Korea
  • 2.2.7 Rest-of-Asia-Pacific

3 Company Profiles

• 3.1 Overview
• 3.2 Burning Rock DX
  • 3.2.1 Company Overview
  • 3.2.2 Role of Burning Rock DX in the Genomic Cancer Panel and Profiling Market
  • 3.2.3 Business Strategies
  • 3.2.4 Analyst Perspective
• 3.3 Genecast Biotechnology Co., Ltd
  • 3.3.1 Company Overview
  • 3.3.2 Role of Genecast Biotechnology Co., Ltd in the Genomic Cancer Panel and Profiling Market
  • 3.3.3 Analyst Perspective

List of Figures

• Figure 1: Asia-Pacific Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
• Figure 2: Asia-Pacific Genomic Cancer Panel and Profiling Market (by Application), % Share, 2022 and 2033
• Figure 3: Asia-Pacific Genomic Cancer Panel and Profiling Market (by End User), % Share 2022 and 2033
• Figure 4: Genomic Cancer Panel and Profiling Market Snapshot (by Region), $Billion, 2022
• Figure 5: Genomic Cancer Panel and Profiling Market Segmentation
• Figure 6: Genomic Cancer Panel and Profiling Market: Research Methodology
• Figure 7: Primary Research Methodology
• Figure 8: Bottom-Up Approach (Segment-Wise Analysis)
• Figure 9: Top-Down Approach (Segment-Wise Analysis)
• Figure 10: Genomic Cancer Panel and Profiling Workflow, End User Perspective
• Figure 11: Genomic Cancer Panel and Profiling Workflow, Laboratory Technician Perspective
• Figure 12: Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
• Figure 13: Genomic Cancer Panel and Profiling Market Snapshot (by Region), $Billion, 2022
• Figure 14: Asia-Pacific Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
• Figure 15: Asia-Pacific Genomic Cancer Panel and Profiling Market (by Application), $Million, 2022-2033
• Figure 16: Asia-Pacific Genomic Cancer Panel and Profiling Market (by End User), $Million, 2022-2033
• Figure 17: Asia-Pacific Genomic Cancer Panel and Profiling Market (by Country), $Billion, 2022-2033
• Figure 18: China Genomic Cancer Panel and Profiling Market, $Million, 2022-2033
• Figure 19: Japan Genomic Cancer Panel and Profiling Market, $Million, 2022-2033
• Figure 20: India Genomic Cancer Panel and Profiling Market, $Million, 2022-2033
• Figure 21: Australia Genomic Cancer Panel and Profiling Market, $Million, 2022-2033
• Figure 22: South Korea Genomic Cancer Panel and Profiling Market, $Million, 2022-2033
• Figure 23: Rest-of-Asia-Pacific Genomic Cancer Panel and Profiling Market, $Million, 2022-2033
• Figure 24: Genomic Cancer Panel and Profiling Market, Total Number of Companies Profiled
• Figure 25: Burning Rock DX: Product Portfolio
• Figure 26: Genecast Biotechnology Co., Ltd: Product Portfolio

List of Tables

• Table 1: Technological Trends in the Genomic Cancer Panel and Profiling Market
• Table 2: Asia-Pacific Genomic Cancer Panel and Profiling Market, Impact Analysis